Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt

Completed

• Conditions: Patients With Upper Gastro-intestinal Symptoms

• Registration Number: NCT01635959
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to calculate the prevalence of gastroesophageal reflux disease (GERD) by mean of GERD-Q questionnaire in patients with upper gastrointestinal tract symptoms in Egypt.

Detailed Description

Prevalence of Gastroesophageal reflux disease (GERD) in patients with upper gastrointestinal tract symptoms in Egypt

Study Timeline

• Study Start: 2012-07
• Study First Submitted: 2012-07-03
• Study First Submitted QC: 2012-07-09
• Study First Posted: 2012-07-10
• Primary Completion: 2014-07
• Study Completion: 2014-07
• Status Verified: 2014-10
• Last Update Submitted: 2014-10-02
• Last Update Posted: 2014-10-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3170

Inclusion Criteria

• 18 years and above
• Attending the medical office and reporting symptoms suggestive of upper gastrointestinal tract symptoms such as heartburn/regurgitation, abdominal pain, bloating, belching and nausea/vomiting.

Exclusion Criteria

• Participating on a clinical trial during the last 3 months.
• Patients not able to read and/or understand the GERD-Q questionnaire.
• Patients already included in the study in other participating site.
• Patients taking PPIs or H2blockers in the l

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of patients scoring ≥ 8 in GERD-Q	baseline	Percentage of patients scoring ≥ 8 in GERD-Q will be considered as suffering from GERD.; The GERD-Q is a potentially useful tool for family practitioners and other health care professionals in diagnosing and managing GERD without initial specialist referral or endoscopy.; The Egyptian-validated version of the GERD-Q will be used for the study purposes.

Secondary Outcome Measures

Name	Time	Method
Treatment patterns in patients diagnosed with gastroesophageal reflux disease (GERD)	baseline	Descriptive analysis of treatment patterns in patients diagnosed with gastroesophageal reflux disease (GERD) in Egypt.
Socio-demographic characteristics of patients diagnosed with gastroesophageal reflux disease (GERD)	baseline	Descriptive analysis of socio-demographic characteristics of patients diagnosed with gastroesophageal reflux disease (GERD) in Egypt.

Trial Locations

Locations (1)

Research Site; 🇪🇬 Tanta, Egypt